Promising efficacy of SHR‐1210, a novel anti–programmed cell death 1 antibody, in patients with advanced gastric and gastroesophageal junction cancer in China - Concepedia

Concepedia

Publication | Open Access

Promising efficacy of SHR‐1210, a novel anti–programmed cell death 1 antibody, in patients with advanced gastric and gastroesophageal junction cancer in China

DOI Full Paper Access

66

Citations

17

References

2018

Year

Jing Huang, Hongnan Mo, Weilong Zhang, Xuelian Chen, Dong Qu, Xi Wang, Dawei Wu, Xingyuan Wang, Bo Lan, Beibei Yang,

Abstract

Anti-PD-1 antibody SHR-1210 shows encouraging efficacy in patients with advanced gastric/GEJ cancer in China, including mismatch repair-proficient subgroups.

References

	Year	Citations

Page 1